News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Good Morning America features story of Emily Whitehead, the first pediatric patient to receive CAR T cell therapy
After receiving CAR T-cell treatment for leukemia in 2012, Emily is now 11 years cancer free, and is heading off to college this fall.
Quantum Technology Innovation at Penn Engineering Receives Major Boost through Multi-Year Collaboration with Quantum Motion Technologies
Quantum Motion Technologies Ltd., a privately held company in London, UK, entered into an R&D collaboration agreement with Penn.
Verismo Therapeutics featured in the Philadelphia Business Journal for recent funding
The cell therapy startup recently raised $17 million to advance its lead immunotherapy candidates in a second pre-Series A round of funding.
Penn Engineering Inventors Develop Metastructures for Solving Equations with Waves
U.S. Patent No. 11, 494,461 “Metastructures for solving equations with waves” was awarded and issued on Nov. 8, 2022.
Advisory Board for IoT4Ag Precision Agriculture Research Center Led by Penn Engineering Gains New Industrial Members
oT4Ag, the NSF-funded Engineering Research Center for precision agriculture led by Penn Engineering, has successfully recruited a diverse group of 19 industry leaders and innovative start-ups.
Philadelphia Business Journal Highlights Philadelphia as Hub for Gene Editing
A new Philadelphia Business Journal article explains how in addition to being a hub for cell and gene therapy, the Philadelphia area is emerging as an active player in the field of gene editing.
Penn Engineering and AlphaThera Expand License Agreement
AlphaThera, a startup company co-founded by Andrew Tsourkas, PhD, entered into an expanded license agreement with Penn.
Verismo Therapeutics raises funding and expands partnership with Penn Medicine
Penn spinout company Verismo Therapeutics has successfully raised $7 million in a pre-Series A round led by BRV Capital Management.
Philadelphia ranks as the 6th best life sciences market in the US
In CBRE’s 2023 Life Sciences Research Talent report, Philadelphia ranked sixth among the top 25 US life sciences markets, two spots above its number eight ranking from last year.
6 Million NIH Grant Funds New Penn Medicine Research on Cardiac Cell Development
The Penn research team, led by principal investigator Dr. Rajan Jain aims to study how cardiac cells establish and maintain their identity over a lifetime.